Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Qin-Yuan Jia"'
Autor:
Yu-Heng Zhu, Qin-Yuan Jia, Hong-Fei Yao, Zong-Hao Duan, Xue-Shi-Yu Ma, Jia-Hao Zheng, Yi-Fan Yin, Wei Liu, Jun-Feng Zhang, Rong Hua, Ding Ma, Yong-Wei Sun, Jian-Yu Yang, De-Jun Liu, Yan-Miao Huo
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-19 (2024)
Abstract Background This study investigated the molecular mechanism of long intergenic non-protein coding RNA 1605 (LINC01605) in the process of tumor growth and liver metastasis of pancreatic ductal adenocarcinoma (PDAC). Methods LINC01605 was filte
Externí odkaz:
https://doaj.org/article/1bacd5c3238b402e9c0a00fb055ea2ff
Autor:
Jia-Hao Zheng, Yu-Heng Zhu, Jian Yang, Pei-Xuan Ji, Rui-Kang Zhao, Zong-Hao Duan, Hong-Fei Yao, Qin-Yuan Jia, Yi-Fan Yin, Li-Peng Hu, Qing Li, Shu-Heng Jiang, Yan-Miao Huo, Wei Liu, Yong-Wei Sun, De-Jun Liu
Publikováno v:
Cell Reports, Vol 43, Iss 8, Pp 114633- (2024)
Summary: Pancreatic ductal adenocarcinoma (PDAC) features substantial matrix stiffening and reprogrammed glucose metabolism, particularly the Warburg effect. However, the complex interplay between these traits and their impact on tumor advancement re
Externí odkaz:
https://doaj.org/article/3e191bdb041148d8ad4a43c8690cab09
Autor:
Jia-Hao Zheng, Hong-Fei Yao, Zong-Hao Duan, Pei-Xuan Ji, Jian Yang, Yu-Heng Zhu, Qin-Yuan Jia, Jian-Yu Yang, De-Jun Liu, Yong-Wei Sun, Peng-Cheng Chen, Pei-Dong Shi, Li Chen
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1336 (2022)
Pancreatic adenocarcinoma (PAAD), one of the most malignant tumors, not only has abundant mesenchymal components, but is also characterized by an extremely high metastatic risk. The purpose of this study was to construct a model of stroma- and metast
Externí odkaz:
https://doaj.org/article/980608430c6143848ce14c867014d020
Autor:
Yu-Heng, Zhu, Jia-Hao, Zheng, Qin-Yuan, Jia, Zong-Hao, Duan, Hong-Fei, Yao, Jian, Yang, Yong-Wei, Sun, Shu-Heng, Jiang, De-Jun, Liu, Yan-Miao, Huo
Publikováno v:
Cellular Oncology. 46:17-48
Pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer, is characterized by poor treatment response and low survival time. The current clinical treatment for advanced PDAC is still not effective. In recent years, the resea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfd0d1a1a24d774f3ffa7725626ab64
https://doi.org/10.1007/s13402-022-00741-1
https://doi.org/10.1007/s13402-022-00741-1
Autor:
Hong-Fei Yao, Da-Peng Xu, Jia-Hao Zheng, Yu Xu, Qin-Yuan Jia, Yu-Heng Zhu, Jian Yang, Rui-Zhe He, Ding Ma, Min-Wei Yang, Xue-Liang Fu, De-Jun Liu, Yan-Miao Huo, Jian-Yu Yang, Jun-Feng Zhang
Publikováno v:
Apoptosis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89884003767c1bc4b8bfb73713ef0dd6
https://doi.org/10.1007/s10495-023-01843-3
https://doi.org/10.1007/s10495-023-01843-3